How I manage patients with relapsed/refractory diffuse large B cell lymphoma
Author:
Affiliation:
1. Hôpital Saint Louis; Paris France
2. Cliniques universitaires UCL Saint-Luc; Brussels Belgium
Publisher
Wiley
Subject
Hematology
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/bjh.15412/fullpdf
Reference72 articles.
1. More on anti-CD19 CAR T cells in CNS diffuse large-B-cell lymphoma;Abramson;The New England Journal of Medicine,2017
2. Bone marrow biopsy involvement by non-Hodgkin's lymphoma: frequency of lymphoma types, patterns, blood involvement, and discordance with other sites in 450 specimens;Arber;The American Journal of Surgical Pathology,2005
3. Discordant bone marrow involvement in non-Hodgkin lymphoma;Brudno;Blood,2016
4. Impact of conditioning regimen on outcomes for patients with lymphoma undergoing high-dose therapy with autologous hematopoietic cell transplantation;Chen;Biology of Blood and Marrow Transplantation: Journal of the American Society for Blood and Marrow Transplantation,2015a
5. Phase II trial of tandem high-dose chemotherapy with autologous stem cell transplantation followed by reduced-intensity allogeneic stem cell transplantation for patients with high-risk lymphoma;Chen;Biology of Blood and Marrow Transplantation: Journal of the American Society for Blood and Marrow Transplantation,2015b
Cited by 133 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Baseline 18F-FDG PET Radiomics Predicting Therapeutic Efficacy of Diffuse Large B-Cell Lymphoma after R-CHOP (-Like) Therapy;Cancer Biotherapy and Radiopharmaceuticals;2024-09-04
2. Follicular lymphoma or diffuse large B-cell lymphoma: a population based analysis of epidemiological and health economic aspects in Germany;2024-09-03
3. Extranodal diffuse large B-cell lymphoma presenting with extensive organ involvement;BMJ Case Reports;2024-06
4. Utilizing red blood cell distribution width (RDW) as a reliable biomarker to predict treatment effects after chimeric antigen receptor T cell therapy;Clinical and Experimental Medicine;2024-05-21
5. Real-world total cost of care by line of therapy in relapsed/refractory diffuse large B-cell lymphoma;Journal of Medical Economics;2024-05-06
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3